Viscoli C - Search Results

1

Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides.

Di Biagio A, Riccardi N, Taramasso L, Capetti A, Cenderello G, Signori A, Vitiello P, Guerra M, de Socio GV, Cassola G, Quirino T, Viscoli C. Di Biagio A, et al. Among authors: viscoli c. Int J Antimicrob Agents. 2016 Nov;48(5):551-554. doi: 10.1016/j.ijantimicag.2016.07.009. Epub 2016 Aug 17. Int J Antimicrob Agents. 2016. PMID: 27566908

2

Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen.

Rosso R, Di Biagio A, Maggiolo F, Nulvesu L, Callegaro AP, Taramasso L, Bruzzone B, Viscoli C. Rosso R, et al. Among authors: viscoli c. AIDS Care. 2012;24(1):54-8. doi: 10.1080/09540121.2011.596511. Epub 2011 Jul 29. AIDS Care. 2012. PMID: 21800951

3

Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B.

Taramasso L, Caligiuri P, Di Biagio A, Bruzzone B, Rosso R, Icardi G, Viscoli C. Taramasso L, et al. Among authors: viscoli c. J Med Virol. 2011 Nov;83(11):1905-8. doi: 10.1002/jmv.22192. J Med Virol. 2011. PMID: 21915864

4

Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults.

Rosso R, Rossotti R, Di Biagio A, Nicolini L, Adorni F, Orani A, Viscoli C. Rosso R, et al. Among authors: viscoli c. Curr Drug Saf. 2011 Jul;6(3):138-44. doi: 10.2174/157488611797579339. Curr Drug Saf. 2011. PMID: 22122388

5

Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients.

Di Biagio A, Rosso R, Loregian A, Pagni S, Sormani MP, Cenderello G, Palù G, Viscoli C. Di Biagio A, et al. Among authors: viscoli c. J Infect Chemother. 2012 Aug;18(4):587-90. doi: 10.1007/s10156-012-0402-y. Epub 2012 Mar 16. J Infect Chemother. 2012. PMID: 22422300

6

Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.

Mikulska M, Taramasso L, Giacobbe DR, Caligiuri P, Bruzzone B, Di Biagio A, Viscoli C. Mikulska M, et al. Among authors: viscoli c. J Med Virol. 2012 Sep;84(9):1340-3. doi: 10.1002/jmv.23338. J Med Virol. 2012. PMID: 22825811

7

The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients.

Di Biagio A, Ricci E, Viscoli C, Mesini A, Menzaghi B, Carenzi L, Orofino G, Parruti G, Martinelli C, Madeddu G, De Socio GV, Franzetti M, Quirino T, Bonfanti P; CISAI Group. Di Biagio A, et al. Among authors: viscoli c. Curr HIV Res. 2013 Apr;11(3):179-86. doi: 10.2174/1570162x113119990036. Curr HIV Res. 2013. PMID: 23432466

8

Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV.

Prinapori R, Rosso R, Di Biagio A, Miletich F, Furfaro E, Taramasso L, Ginocchio F, Giacomet V, Nulvesu L, Sormani MP, Schiavetti I, Signori A, De Hoffer L, Viscoli C. Prinapori R, et al. Among authors: viscoli c. Indian J Pediatr. 2014 Sep;81(9):856-60. doi: 10.1007/s12098-013-1198-1. Epub 2013 Sep 7. Indian J Pediatr. 2014. PMID: 24014186 Free article.

9

Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapy.

Di Biagio A, Parisini A, Bruzzone B, Prinapori R, Lauriola M, Paolucci S, Signori A, Barresi R, Icardi G, Calderisi S, Meini G, Dentone C, Cenderello G, Guerra M, Maccabruni A, Rusconi S, Viscoli C. Di Biagio A, et al. Among authors: viscoli c. HIV Clin Trials. 2014 Jan-Feb;15(1):45-50. doi: 10.1310/hct1501-45. HIV Clin Trials. 2014. PMID: 24518213

10

Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?

Di Biagio A, Prinapori R, Taramasso L, Gustinetti G, Sticchi L, Bruzzone B, Viscoli C. Di Biagio A, et al. Among authors: viscoli c. Recent Pat Antiinfect Drug Discov. 2014;9(1):41-51. doi: 10.2174/1574891x09666140717102358. Recent Pat Antiinfect Drug Discov. 2014. PMID: 25030944 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

565 results

Search Page